Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.
As with the global pharmaceutical industry, the local industry is currently contending with the fallout associated with the patent cliff. Between 2011 and 2015, some of the world's highest selling drugs have already lost or are due to lose patent protection... purchase to read more
Industry Report - Starting a New Business Chapter
Substantial barriers to entry to the industry exist, not least of which is the fact that the industry is becoming increasingly globalised, with the dominant major players operating on a large global scale.
The high and rising costs of R&D, combined with declining R&D productivity pose another substantial obstacle. In Australia, the pharmaceutical industry is one of the country's most innovative manufacturing industries. High levels of capital expenditure are also required at the onset to establish a manufacturing plant geared to producing high-cost, high-technology drugs.
Government policies can be significant barriers to entry... purchase to read more